Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.
Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ. Gadoth A, et al. Among authors: schmeling je. Ann Neurol. 2017 Jul;82(1):79-92. doi: 10.1002/ana.24979. Ann Neurol. 2017. PMID: 28628235
Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD.
Jitprapaikulsan J, Fryer JP, Majed M, Smith CY, Jenkins SM, Cabre P, Hinson SR, Weinshenker BG, Mandrekar J, Chen JJ, Lucchinetti CF, Jiao Y, Segan J, Schmeling JE, Mills J, Flanagan EP, McKeon A, Pittock SJ. Jitprapaikulsan J, et al. Among authors: schmeling je. Neurol Neuroimmunol Neuroinflamm. 2020 May 28;7(4):e727. doi: 10.1212/NXI.0000000000000727. Print 2020 Jul. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 35413004 Free PMC article.